AGT and obesity due to melanocortin 4 receptor deficiency: Four wks of AngII-treatment did not affect body weight, tibia length, liver weight (Table 1) and blood glucose levels (Figure 1B), indicating that AngII did not influence obesity or the severity of diabetes.